Loading...
NPI 1598315574 · Cedar Knolls, NJ · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Centers Lab Nj LLC is a clinical medical laboratory provider located in Cedar Knolls, New Jersey. This profile covers 342 Medicare and 259 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Centers Lab Nj LLC |
| Address | 85 Horsehill Rd Ste 110 |
| City | Cedar Knolls |
| State | NJ |
| ZIP | 07927 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | September 12, 2019 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $27.8M |
| Medicare | $15.4M |
CENTERS LAB NJ LLC is a high-volume clinical laboratory with substantial activity across both Medicare and Medicaid: lifetime Medicare revenue is $15.4M while lifetime Medicaid revenue is $27.8M, indicating Medicaid accounts for the larger share of reported public-payer dollars. The mix of high-volume routine chemistry and hematology panels (80053, 80048, 80061, 85025) alongside extensive molecular infectious testing (U0003, U0005, 87631/87635) suggests an operation that combines high-throughput core lab services with large-scale COVID-19 and respiratory pathogen molecular testing.
Revenue concentration differs markedly by payer: for Medicare the provider’s top three codes by revenue account for 35.4% of total Medicare revenue, signaling moderate concentration among leading services. By contrast, Medicaid revenue is heavily concentrated with the top three codes accounting for 74.8% of total Medicaid revenue, reflecting a much stronger reliance on a narrow set of services — primarily molecular SARS-CoV-2 testing (U0003, U0005) and high-volume rapid pathogen assays.
Several individual codes show extreme national or state-level dominance that define the provider’s footprint. On Medicare, codes like P9603, G0471, 85025, 80053 and 80048 are labeled as extreme outliers or at the 100th percentile nationally, and P9603 alone represents $1.6M (13.0% of Medicare revenue) with a rank of #5 of 267 nationally. On Medicaid, U0003 ($14M, 55.2% of Medicaid revenue) and U0005 ($4M, 16.0% of Medicaid revenue) together dominate Medicaid revenue, and P9603 ranks #1 in-state — these rank/percentile signals indicate the provider is a major state-level player for COVID-19 molecular testing and specimen-collection travel allowances.
The payer-specific code mix implies distinct operational channels: the Medicare profile includes large volumes of specimen-collection (P9603), SNF/HHA venipuncture collections (G0471), and routine laboratory panels (85025, 80053), which points to strong relationships with skilled nursing facilities and outpatient ordering sources. The Medicaid profile is even more concentrated in high-volume molecular infectious testing (U0003, U0005) and related multiplex respiratory codes (87633, 87631), indicating a lab configured for high-throughput NAAT processing and rapid-turnaround workflows that served Medicaid populations heavily during the COVID-19 era.
Competitive standing varies by code and payer: nationally for Medicare this lab is an extreme outlier on many routine and molecular codes (multiple codes at the 100th percentile or near it), meaning its Medicare volumes are far above typical national peers for those services. In-state for Medicaid the provider ranks in top deciles for core molecular codes (U0003 rank #7 of 127 but generating $14M and 55.2% of Medicaid revenue) and holds top positions for specimen-collection travel (P9603 rank #1 in-state), showing clear dominance in select Medicaid service lines even if some ranks are described as typical for volume.
The provider has been enumerated since 2019-09-12 (~7 years ago), which aligns with the emergence of COVID-19 testing demand; its billing footprint—large U0003/U0005 volumes on Medicaid and high Medicare SNF/home-collection codes—supports the interpretation of rapid scale-up into high-throughput molecular testing and collection services during its tenure. This relatively recent enumeration plus the skew toward pandemic-era testing codes suggests a growth trajectory tied to infectious-disease testing capacity.
Statistical outlier labels reinforce operational specialization rather than routine parity with peers: multiple Medicare codes are flagged as "extreme outlier" or at the 100th percentile (for example 85025, 80053, 80048), and several Medicaid codes are top-ranked in-state (P9603 at rank #1, G2024 at rank #2 in-state). These descriptors indicate that for many routine and collection codes the provider’s volumes are far above typical peer levels, which has implications for network contracting, capacity planning, and oversight by payers seeking to understand unusually concentrated billings.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
342 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 1,616,770 | $1 | $1.6M |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 157,830 | $10 | $1.6M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 16,390 | $70 | $1.2M |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 147,010 | $10 | $1.2M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 105,260 | $10 | $1.1M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 45,820 | $20 | $733.1K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 20,760 | $30 | $602K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 42,350 | $10 | $550.5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 16,350 | $30 | $408.9K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 43,100 | $10 | $344.8K |
Showing 1–10 of 342
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 342 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
342 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| G0471 | 2 | 10 | 25,620 | $10 | $699.5K |
| 87506 | 5 | 10 | 110 | $260 | $506.1K |
| 87798 | 16 | 40 | 1,760 | $30 | $284.3K |
| P9603 | 1 | 10 | 11,620 | $1 | $245.2K |
| 81513 | 3 | 10 | 60 | $140 | $217.2K |
| 87536 | 4 | 10 | 2,150 | $80 | $207K |
| 87799 | 4 | 10 | 4,810 | $40 | $202.8K |
| 86769 | 5 | 20 | 100 | $40 | $140.5K |
| 86480 | 4 | 20 | 50 | $60 | $110.8K |
| U0003 | 2 | 80 | 110 | $70 | $101.7K |
Showing 1–10 of 342
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
259 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 249,340 | $60 | $14M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 224,970 | $20 | $4M |
| 87651 | The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat. | 89,530 | $10 | $895.3K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 11,200 | $70 | $828.7K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 25,190 | $30 | $755.6K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 16,010 | $40 | $656.3K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 145,780 | $1 | $583.1K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 39,520 | $10 | $434.7K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 198,280 | $1 | $396.6K |
| 86769 | The lab analyst performs a multiple–step immunoassay to evaluate the patient’s serum for antibodies to severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), which causes coronavirus disease… | 9,150 | $30 | $274.6K |
Showing 1–10 of 259
How this provider's Medicaid billing volume and revenue compare to other New Jersey providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Jersey median
259 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 7 | 130 | 3,180 | $60 | $4.2M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 8 | 40 | 590 | $20 | $1.9M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 39 | 150 | 3,680 | $30 | $1.5M |
| 86480 | The lab analyst performs a test to evaluate a cell mediated immunity gamma interferon antigen response to certain tuberculosis, or TB, antibodies. | 10 | 40 | 810 | $30 | $1.4M |
| 88175 | The lab analyst performs the technical lab test to analyze a cervical or vaginal cytopathology specimen that a clinician collected in preservative fluid. The test uses automated thin layer… | 7 | 20 | 750 | $10 | $1.3M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 16 | 120 | 900 | $20 | $971.9K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 16 | 120 | 940 | $20 | $957.4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 53 | 110 | 1,810 | $50 | $930.1K |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 9 | 20 | 930 | $40 | $914.5K |
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 9 | 20 | 810 | $50 | $856K |
Showing 1–10 of 259
Other providers in the same ZIP code as Centers Lab Nj LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.